vs
STANDARD BIOTOOLS INC.（LAB）与TERAWULF INC.（WULF）财务数据对比。点击上方公司名可切换其他公司
TERAWULF INC.的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$26.1M vs $19.6M），STANDARD BIOTOOLS INC.净利率更高（-177.4% vs -484.2%，领先306.8%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -25.3%），STANDARD BIOTOOLS INC.自由现金流更多（$-23.1M vs $-1.2B），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -21.5%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
TeraWulf Inc.是美国比特币挖矿企业，2021年成立，于纳斯达克挂牌上市，股票交易代码为WULF，目前在纽约州、宾夕法尼亚州两地运营加密货币矿场，核心业务围绕比特币挖矿展开。
LAB vs WULF — 直观对比
营收规模更大
WULF
是对方的1.3倍
$19.6M
营收增速更快
LAB
高出13.8%
-25.3%
净利率更高
LAB
高出306.8%
-484.2%
自由现金流更多
LAB
多$1.2B
$-1.2B
两年增速更快
LAB
近两年复合增速
-21.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $26.1M |
| 净利润 | $-34.7M | $-126.6M |
| 毛利率 | 48.5% | 27.7% |
| 营业利润率 | -168.5% | -330.2% |
| 净利率 | -177.4% | -484.2% |
| 营收同比 | -11.5% | -25.3% |
| 净利润同比 | -28.8% | -333.5% |
| 每股收益（稀释后） | $-0.09 | $-0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABWULF
| Q4 25 | — | $26.1M | ||
| Q3 25 | $19.6M | $50.6M | ||
| Q2 25 | $21.8M | $47.6M | ||
| Q1 25 | $40.8M | $34.4M | ||
| Q4 24 | — | $35.0M | ||
| Q3 24 | $22.1M | $27.1M | ||
| Q2 24 | $22.5M | $35.6M | ||
| Q1 24 | $45.5M | $42.4M |
净利润LABWULF
| Q4 25 | — | $-126.6M | ||
| Q3 25 | $-34.7M | $-455.1M | ||
| Q2 25 | $-33.5M | $-18.4M | ||
| Q1 25 | $-26.0M | $-61.4M | ||
| Q4 24 | — | $-29.2M | ||
| Q3 24 | $-26.9M | $-22.7M | ||
| Q2 24 | $-45.7M | $-10.9M | ||
| Q1 24 | $-32.2M | $-9.6M |
毛利率LABWULF
| Q4 25 | — | 27.7% | ||
| Q3 25 | 48.5% | 57.2% | ||
| Q2 25 | 48.8% | 53.6% | ||
| Q1 25 | 48.4% | 28.6% | ||
| Q4 24 | — | 26.6% | ||
| Q3 24 | 54.9% | 40.0% | ||
| Q2 24 | 46.1% | 60.9% | ||
| Q1 24 | 53.1% | 66.0% |
营业利润率LABWULF
| Q4 25 | — | -330.2% | ||
| Q3 25 | -168.5% | -48.8% | ||
| Q2 25 | -118.1% | -32.7% | ||
| Q1 25 | -80.8% | -173.3% | ||
| Q4 24 | — | -147.0% | ||
| Q3 24 | -120.9% | -58.1% | ||
| Q2 24 | -134.5% | -19.0% | ||
| Q1 24 | -132.2% | -5.5% |
净利率LABWULF
| Q4 25 | — | -484.2% | ||
| Q3 25 | -177.4% | -899.7% | ||
| Q2 25 | -153.7% | -38.6% | ||
| Q1 25 | -63.8% | -178.5% | ||
| Q4 24 | — | -83.5% | ||
| Q3 24 | -122.0% | -84.0% | ||
| Q2 24 | -203.3% | -30.6% | ||
| Q1 24 | -70.6% | -22.7% |
每股收益（稀释后）LABWULF
| Q4 25 | — | $-0.32 | ||
| Q3 25 | $-0.09 | $-1.13 | ||
| Q2 25 | $-0.09 | $-0.05 | ||
| Q1 25 | $-0.07 | $-0.16 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | $-0.07 | $-0.06 | ||
| Q2 24 | $-0.12 | $-0.03 | ||
| Q1 24 | $-0.27 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $3.3B |
| 总债务越低越好 | — | $3.1B |
| 股东权益账面价值 | $399.7M | $140.4M |
| 总资产 | $539.6M | $6.6B |
| 负债/权益比越低杠杆越低 | — | 22.06× |
8季度趋势，按日历期对齐
现金及短期投资LABWULF
| Q4 25 | — | $3.3B | ||
| Q3 25 | $129.4M | $711.3M | ||
| Q2 25 | $158.6M | $90.0M | ||
| Q1 25 | $150.9M | $218.2M | ||
| Q4 24 | — | $274.1M | ||
| Q3 24 | $210.6M | $23.9M | ||
| Q2 24 | $269.8M | $104.1M | ||
| Q1 24 | $287.1M | $45.8M |
总债务LABWULF
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $55.2M | $0 | ||
| Q2 24 | $55.1M | $72.3M | ||
| Q1 24 | $55.0M | $99.4M |
股东权益LABWULF
| Q4 25 | — | $140.4M | ||
| Q3 25 | $399.7M | $247.3M | ||
| Q2 25 | $424.5M | $174.3M | ||
| Q1 25 | $454.6M | $170.4M | ||
| Q4 24 | — | $244.4M | ||
| Q3 24 | $489.3M | $372.6M | ||
| Q2 24 | $510.3M | $386.2M | ||
| Q1 24 | $577.3M | $272.3M |
总资产LABWULF
| Q4 25 | — | $6.6B | ||
| Q3 25 | $539.6M | $2.5B | ||
| Q2 25 | $557.0M | $869.4M | ||
| Q1 25 | $579.6M | $841.2M | ||
| Q4 24 | — | $787.5M | ||
| Q3 24 | $681.5M | $405.9M | ||
| Q2 24 | $708.7M | $479.6M | ||
| Q1 24 | $777.7M | $395.4M |
负债/权益比LABWULF
| Q4 25 | — | 22.06× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 0.11× | 0.00× | ||
| Q2 24 | 0.11× | 0.19× | ||
| Q1 24 | 0.10× | 0.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-123.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-1.2B |
| 自由现金流率自由现金流/营收 | -118.1% | -4527.0% |
| 资本支出强度资本支出/营收 | 4.5% | 4055.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-1.7B |
8季度趋势，按日历期对齐
经营现金流LABWULF
| Q4 25 | — | $-123.2M | ||
| Q3 25 | $-22.2M | $-36.7M | ||
| Q2 25 | $-20.7M | $-54.8M | ||
| Q1 25 | $-30.3M | $56.5M | ||
| Q4 24 | — | $-24.4M | ||
| Q3 24 | $-27.9M | $-20.9M | ||
| Q2 24 | $-39.0M | $16.4M | ||
| Q1 24 | $-62.5M | $22.8M |
自由现金流LABWULF
| Q4 25 | — | $-1.2B | ||
| Q3 25 | $-23.1M | $-268.3M | ||
| Q2 25 | $-22.6M | $-174.8M | ||
| Q1 25 | $-35.3M | $-37.2M | ||
| Q4 24 | — | $-292.4M | ||
| Q3 24 | $-30.1M | $-41.7M | ||
| Q2 24 | $-41.0M | $-30.2M | ||
| Q1 24 | $-63.3M | $-24.1M |
自由现金流率LABWULF
| Q4 25 | — | -4527.0% | ||
| Q3 25 | -118.1% | -530.4% | ||
| Q2 25 | -103.6% | -366.8% | ||
| Q1 25 | -86.6% | -108.1% | ||
| Q4 24 | — | -835.7% | ||
| Q3 24 | -136.4% | -153.9% | ||
| Q2 24 | -182.2% | -84.9% | ||
| Q1 24 | -138.9% | -56.9% |
资本支出强度LABWULF
| Q4 25 | — | 4055.8% | ||
| Q3 25 | 4.5% | 457.8% | ||
| Q2 25 | 8.7% | 251.8% | ||
| Q1 25 | 12.4% | 272.3% | ||
| Q4 24 | — | 765.9% | ||
| Q3 24 | 10.2% | 76.6% | ||
| Q2 24 | 8.6% | 131.0% | ||
| Q1 24 | 1.7% | 110.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
WULF
暂无分部数据
